Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04684875 · ClinicalTrials.gov registry record
Quality of Life Impact of Chronic Rhinitis Treatment With Aerin Medical Device
A clinical trial, sponsored by Aerin Medical.
- Completed
- Registry status
- 45
- Enrollment target
NCT04684875: Completed study, sponsored by Aerin Medical.
NCT04684875 is a clinical trial that has completed, run by Aerin Medical. The registered enrollment target is 45 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04684875 has completed, sponsored by Aerin Medical.
- COMPLETED
- Registry status
- 45 participants
- Enrollment target
Study Summary
Evaluation of long-term (2-year) quality of life and symptoms after chronic rhinitis treatment with the Aerin InSeca/RhinAer Stylus
Primary Outcome
Mean change in reflective Total Nasal Symptom Score (rTNSS) from baseline. The TNSS is an instrument used to collect patient self-rated severity of rhinorrhea, nasal congestion, nasal itching and sneezing. In this study, a reflective score will be collected, in which the subject will be asked to evaluate symptom severity over the preceding 12 hours. Symptom severity is rated on a 4-point scale of 0 (absent symptoms), 1 (mild symptoms), 2 (moderate symptoms, or 3 (severe symptoms), with the total
Interventions
- DEVICE Radiofrequency Stylus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2020-11-19 |
| Est. Completion | 2022-01-01 |
What the finished NCT04684875 record still lists
NCT04684875 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 45 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Radiofrequency Stylus is the first listed.
NCT04684875 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04684875 about?
NCT04684875 is a clinical study titled "Quality of Life Impact of Chronic Rhinitis Treatment With Aerin Medical Device". Evaluation of long-term (2-year) quality of life and symptoms after chronic rhinitis treatment with the Aerin InSeca/RhinAer Stylus
What is the current status of trial NCT04684875?
This trial is currently completed. The enrollment target is 45 participants. The study started on 2020-11-19. Estimated completion is 2022-01-01.
What interventions are being tested in trial NCT04684875?
The interventions under investigation include: Radiofrequency Stylus (DEVICE).
Who is sponsoring clinical trial NCT04684875?
This trial is sponsored by Aerin Medical, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI